Enrica Mezzalana

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

MJ Swat, Stuart Moodie, NR Kristensen et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 38 citations · Full text

Medicine, Pharmacology, Drug Design +6

A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine

Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana et al. · Pharmaceutics · 2020 · 25 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes

Yoshiko Tomita, Emma Hansson, Florent Mazuir et al. · Clinical and Translational Science · 2021 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis

Roberto Bizzotto, Stefano Zamuner, Enrica Mezzalana et al. · The AAPS Journal · 2011 · 12 citations · Full text

Medicine, Biostatistics, Sleep Medicine +13

Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients

Georgios Vlasakakis, Antonella Napolitano, Ruth M. Barnard et al. · British Journal of Clinical Pharmacology · 2018 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15